This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William M. Crist, MD; Abdelsalam H. Ragab, MD; Teresa J. Vietti, MD; Rafael Ducos, MD; Jen-Yih Chu, MD

Am J Dis Child. 1976;130(6):639-642.

Abstract
• A number of chemotherapeutic agents have been shown to have antitumor activity against childhood medulloblastoma. Ten-year survival with optimal surgery and radiation therapy ranges from 5% to 25%. Carefully controlled clinical trials utilizing a combination of surgery, radiation therapy, and chemotherapy should be employed in the early stages of the disease in an attempt to define which drugs are most effective, and to improve the survival rate.

(Am J Dis Child 130:639-642, 1976)

Author Affiliations
From the Edward Mallinckrodt Department of Pediatrics, Washington University, and the Division of Pediatric Hematology and Oncology, St Louis Children's Hospital, St Louis. Dr Crist is currently with the Department of Pediatrics and the Division of Hematology and Oncology, Children's Hospital, University of Alabama School of Medicine, Birmingham. Dr Ragab is currently with the Department of Pediatrics, Emory University School of Medicine, Atlanta.

Footnotes
Received for publication March 13, 1975; accepted July 13.

Reprint requests to the Children's Hospital, 1601 Sixth Ave S, Birmingham, AL 35233 (Dr Crist).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cerebellar Medulloblastoma: An Analysis of Four Cases of Extraneural Metastasis
Schnitzler et al.
Arch Pediatr Adolesc Med 1978;132:1004-1008.
ABSTRACT